Efficacy of Antiresorptive Treatment in Osteoporotic Older Adults: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
ConclusionsAntiresorptive drugs have a statistically significant effect on preventing hip fracture but with a moderate quality (unclear/high risk of bias) and high NNT (186). This small benefit disappears in those ≥75 years, but increases in secondary prevention. More RCTs in very old osteoporotic adults are needed.
Source: The Journal of Nutrition, Health and Aging - Category: Nutrition Source Type: research
More News: Cancer | Cancer & Oncology | Clinical Trials | Corticosteroid Therapy | Databases & Libraries | Nutrition | Orthopaedics | Osteoporosis | Science | Statistics | Study